Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
RxSight, Inc. shareholders approved Election of Three Class II Directors at the 2026-06-16 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-06-16
Exact text from the filing
1. Election of Three Class II Directors. The following nominees were re-elected by the holders of our common stock to serve as our Class II directors to hold office until our 2029 annual meeting of stockholders and until their successors have been duly elected and qualified: Nominee For Against Abstain Broker Non-Votes William J. Link 21,086,793 — 2,935,396 9,277,003 Robert Warner 15,667,180 — 8,355,009 9,277,003 Shweta Singh Maniar 13,850,389 — 10,171,800 9,277,003
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
RxSight, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-16 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-06-16
Exact text from the filing
3. Ratification of Appointment of Independent Registered Public Accounting Firm. The appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified based on the following results of voting: For Against Abstain Broker Non-Votes 33,062,585 92,653 143,954 —
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
RxSight, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2026-06-16 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-06-16
Exact text from the filing
2. Advisory Vote on Executive Compensation. The stockholders approved, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement based on the following results of voting: For Against Abstain Broker Non-Votes 21,236,615 2,742,189 43,385 9,277,003
View on SEC.gov